Welcome to our dedicated page for Oxford Square Capital news (Ticker: $OXSQ), a resource for investors and traders seeking the latest updates and insights on Oxford Square Capital stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Oxford Square Capital's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Oxford Square Capital's position in the market.
Oxford Square Capital Corp. announced its financial results for Q1 2024, including a NAV per share of $2.42, NII of $6.5 million, total investment income of $10.7 million, and expenses of $4.1 million. The company issued common stock, resulting in net proceeds of $923,000. As of March 31, 2024, the company had 6 debt investments on non-accrual status. The company will hold a conference call on May 2nd to discuss results.
Oxford Square Capital Corp. has scheduled a conference call to discuss its first quarter 2024 earnings on May 2, 2024. Shareholders and interested parties can join the call to gain insights into the company's financial performance.
